# Argolyn Bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/argolyn-bioscience

- Industry: Biotechnology
- Headquarters: Durham, US
- Total disclosed funding: $4.8M
- Latest round: Series A (Jun 5, 2007)
- Investors on record: 3

## About

Argolyn Bioscience Inc. is a privately held biopharmaceutical company dedicated to discovering and developing novel peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders.

## Funding rounds

- Series A, Jun 5, 2007, $4.8M — Intersouth Partners, Quaker Partners Management, Amgen Ventures

## Investors

- Intersouth Partners (https://capitalatlas.ai/funds/intersouth-partners) — Series A
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series A
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series A